Results 111 to 120 of about 25,921 (246)

Artificial Intelligence for Regulatory Evidence: A Systematic Document Analysis of European Medicines Agency Regulatory Advice and Public Reports

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 224-235, July 2026.
Artificial intelligence (AI) is receiving increasing attention across the entire lifecycle of medicines, from early development to postauthorization use. While various AI tools have been developed in commercial and academic settings, the extent of their use in regulatory contexts within the European Union remains unknown.
Lucina‐May Nollen   +3 more
wiley   +1 more source

The promotion of data sharing in pharmacoepidemiology

open access: yes, 2014
This article addresses the role of pharmacoepidemiology in patient safety and the crucial role of data sharing in ensuring that such activities occur. Against the backdrop of proposed reforms of European data protection legislation, it considers whether ...
Sethi, Nayha
core   +1 more source

Risk of SARS‐CoV‐2 Infection and Hospitalisation in Immunocompromised Children: A Population‐Based Cohort Study in Italy and Norway

open access: yesActa Paediatrica, Volume 115, Issue 7, Page 1451-1460, July 2026.
ABSTRACT Aim Immunocompromised children (IC) were presumed to be at higher risk of SARS‐COV‐2 infection and severe COVID‐19, but population‐based evidence is limited. We assessed infection risk, COVID‐19 hospitalisation, and severe outcomes in IC compared with children with and without other high‐risk conditions.
Costanza Di Chiara   +13 more
wiley   +1 more source

Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register‐Based Study

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 1, July 2026.
ABSTRACT Background Zopiclone was recently identified as a frequent contributor to fatal drug‐intoxications in Sweden. However, characteristics of misuse and factors associated with prescribed use remain insufficiently described. Alprazolam has a more established misuse profile. Objective The aim of the study was to describe and compare characteristics
Lova Tralla   +4 more
wiley   +1 more source

Cost-Effectiveness of Itopride Hydrochloride for the Treatment of Functional Dyspepsia in Vietnam

open access: yesPharmacoepidemiology
Background/Objectives: Functional dyspepsia is associated with abdominal pain and nausea, which leads to reduced quality of life, loss of productivity, and economic loss for patients.
Hansoo Kim   +5 more
doaj   +1 more source

The Asian Pharmacoepidemiology Network (AsPEN) : promoting multi-national collaboration for pharmacoepidemiologic research in Asia

open access: yes
The Asian Pharmacoepidemiology Network (AsPEN) is a multi-national research network, which was formed to provide a mechanism to support the conduct of pharmacoepidemiological research and to facilitate the prompt identification and validation of emerging
Setoguchi, Soko   +18 more
core  

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5767-5778, July 2026.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström   +10 more
wiley   +1 more source

Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients

open access: yesPharmacoepidemiology
Background/Objectives: Direct oral anticoagulants (DOACs), when compared to the Vitamin K antagonist (VKA) warfarin, exhibit greater safety and effectiveness.
Shu-Yu Yao   +3 more
doaj   +1 more source

Innovative Approaches for Pharmaceutical Policy Research in Developing Countries: The View Through a Market Lens

open access: yes, 2011
Despite one-third of the world lacking access to essential medicines, a dearth of pharmaceutical policy research in developing countries has resulted in policy decisions based upon opinion and conventional wisdom rather than evidence.
Pharmacoepidemiology   +2 more
core  

Home - About - Disclaimer - Privacy